You can buy now, pay later for weight-loss drugs: Here's what you need to know
Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Insurance Coverage For Ozempic, Zepbound Went Down In 2025
While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
The Business Journals16d
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
Businesses are facing pressure on multiple fronts to coverage popular weight ... loss — has become a flashpoint between insurers, employers and workers in recent months. Those drugs are commonly known ...
Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
Modern Healthcare2d
Optum, CVS, Express Scripts GLP-1 programs entice employers
Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...
ConsumerAffairs7d
Time to crack down on compounded GLP-1 drugs, health groups say
A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...
Healthline9d
Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know
Iuliia Burmistrova/Getty Images The FDA has ordered compounding pharmacies to stop making less expensive versions of popular weight loss medications like Ozempic and Zepbound. The order comes ...
The Business Journals16d
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
Businesses are facing pressure on multiple fronts to coverage popular weight-loss drugs ... including anti-obesity medications. An open letter to employers from the Alliance for Women’s Health ...